CASP8 SNP D302H (rs1045485) is associated with worse survival in MYCN-amplified neuroblastoma patients
- Author
- Ali Rihani (UGent) , Bram De Wilde (UGent) , Fjoralba Zeka (UGent) , Genevieve Laureys (UGent) , Nadine Francotte, Gian Paolo Tonini, Simona Coco, Rogier Versteeg, Rosa Noguera, Johannes Schulte, Angelika Eggert, Raymond Stallings, Franki Speleman (UGent) , Jo Vandesompele (UGent) and Tom Van Maerken (UGent)
- Organization
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-8556896
- MLA
- Rihani, Ali, et al. “CASP8 SNP D302H (Rs1045485) Is Associated with Worse Survival in MYCN-Amplified Neuroblastoma Patients.” OncoPoint, 2nd Meeting, Abstracts, 2014.
- APA
- Rihani, A., De Wilde, B., Zeka, F., Laureys, G., Francotte, N., Tonini, G. P., … Van Maerken, T. (2014). CASP8 SNP D302H (rs1045485) is associated with worse survival in MYCN-amplified neuroblastoma patients. OncoPoint, 2nd Meeting, Abstracts. Presented at the 2nd OncoPoint meeting, Ghent, Belgium.
- Chicago author-date
- Rihani, Ali, Bram De Wilde, Fjoralba Zeka, Genevieve Laureys, Nadine Francotte, Gian Paolo Tonini, Simona Coco, et al. 2014. “CASP8 SNP D302H (Rs1045485) Is Associated with Worse Survival in MYCN-Amplified Neuroblastoma Patients.” In OncoPoint, 2nd Meeting, Abstracts.
- Chicago author-date (all authors)
- Rihani, Ali, Bram De Wilde, Fjoralba Zeka, Genevieve Laureys, Nadine Francotte, Gian Paolo Tonini, Simona Coco, Rogier Versteeg, Rosa Noguera, Johannes Schulte, Angelika Eggert, Raymond Stallings, Franki Speleman, Jo Vandesompele, and Tom Van Maerken. 2014. “CASP8 SNP D302H (Rs1045485) Is Associated with Worse Survival in MYCN-Amplified Neuroblastoma Patients.” In OncoPoint, 2nd Meeting, Abstracts.
- Vancouver
- 1.Rihani A, De Wilde B, Zeka F, Laureys G, Francotte N, Tonini GP, et al. CASP8 SNP D302H (rs1045485) is associated with worse survival in MYCN-amplified neuroblastoma patients. In: OncoPoint, 2nd Meeting, Abstracts. 2014.
- IEEE
- [1]A. Rihani et al., “CASP8 SNP D302H (rs1045485) is associated with worse survival in MYCN-amplified neuroblastoma patients,” in OncoPoint, 2nd Meeting, Abstracts, Ghent, Belgium, 2014.
@inproceedings{8556896, author = {{Rihani, Ali and De Wilde, Bram and Zeka, Fjoralba and Laureys, Genevieve and Francotte, Nadine and Tonini, Gian Paolo and Coco, Simona and Versteeg, Rogier and Noguera, Rosa and Schulte, Johannes and Eggert, Angelika and Stallings, Raymond and Speleman, Franki and Vandesompele, Jo and Van Maerken, Tom}}, booktitle = {{OncoPoint, 2nd Meeting, Abstracts}}, language = {{eng}}, location = {{Ghent, Belgium}}, title = {{CASP8 SNP D302H (rs1045485) is associated with worse survival in MYCN-amplified neuroblastoma patients}}, year = {{2014}}, }